Identification and function of adenosine A3 receptor in afferent arterioles

American Journal of Physiology - Renal Physiology

Volumn 308, Issue 9, 2015, Pages F1020-F1025

  Lu, Yan ^a,b   Zhang, Rui ^a   Ge, Ying ^c   Carlstrom, Mattias ^d   Wang, Shaohui ^a   Fu, Yiling ^a   Cheng, Liang ^a   Wei, Jin ^a   Roman, Richard J ^c   Wang, Lei ^a   Gao, Xichun ^a   Liu, Ruisheng ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

A3 receptor; Adenosine; Af art; Tubuloglomerular feedback

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; ADENOSINE A3 RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; MESSENGER RNA; NORADRENALIN; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST;

AFFERENT ARTERIOLE; ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENE FUNCTION; KIDNEY BLOOD VESSEL; MALE; MICRODISSECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASODILATATION; ANIMAL; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECTS; GENETICS; KIDNEY; KIDNEY CIRCULATION; METABOLISM; SIGNAL TRANSDUCTION; VASCULARIZATION;

ADENOSINE A3 RECEPTOR AGONISTS; ANGIOTENSIN II; ANIMALS; ARTERIOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY; MALE; MICE, INBRED C57BL; RECEPTOR CROSS-TALK; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A3; RECEPTORS, ADENOSINE A2; RENAL CIRCULATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASODILATION;

EID: 84930831398     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00422.2014     Document Type: Article

References (41)

1. Al-Mashhadi RH, Skott O, Vanhoutte PM, Hansen PB. Activation of A(2) adenosine receptors dilates cortical efferent arterioles in mouse. Kidney Int 75: 793–799, 2009
2. 1 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 281: R1362–R1367, 2001
3. Carlstrom M, Lai EY, Steege A, Sendeski M, Ma Z, Zabihi S, Eriksson UJ, Patzak A, Persson AE. Nitric oxide deficiency and increased adenosine response of afferent arterioles in hydronephrotic mice with hypertension. Hypertension 51: 1386–1392, 2008
4. 2A receptor activation attenuates tubuloglomerular feedback responses by stimulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 300: F457–F464, 2011
5. 2 receptors modulate tubuloglomerular feedback. Am J Physiol Renal Physiol 299: F412–F417, 2010.
6. Carmines PK, Ohishi K, Ikenaga H. Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus. J Clin Invest 98: 2564–2571, 1996.
7. Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, Freeman TC. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118: 1461–1468, 1996
8. 2B receptor activation. Am J Physiol Renal Physiol 299: F310–F315, 2010
9. 3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br J Pharmacol 109: 3–5, 1993
10. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. Nomenclature and classification of purinoceptors. Pharmacol Rev 46: 143–156, 1994
11. Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U, Williams M. Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci 18: 79–82, 1997
12. Gao X, Patzak A, Sendeski M, Scheffer PG, Teerlink T, Sallstrom J, Fredholm BB, Persson AE, Carlstrom M. Adenosine A(1)-receptor deficiency diminishes afferent arteriolar and blood pressure responses during nitric oxide inhibition and angiotensin II treatment. Am J Physiol Regul Integr Comp Physiol 301: R1669–R1681, 2011
13. 3 adenosine receptors for the protective effect of inosine in vivo. Blood 102: 4472–4478, 2003
14. 2 adenosine receptors. J Pharmacol Exp Ther 315: 1150–1157, 2005
15. Hashimoto S, Huang Y, Briggs J, Schnermann J. Reduced autoregulatory effectiveness in adenosine 1 receptor-deficient mice. Am J Physiol Renal Physiol 290: F888–F891, 2006
16. Jackson EK, Zhu C, Tofovic SP. Expression of adenosine receptors in the preglomerular microcirculation. Am J Physiol Renal Physiol 283: F41–F51, 2002
17. 3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest 100: 2849–2857, 1997
18. Klotz KN. Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol 362: 382–391, 2000
19. Lai EY, Patzak A, Steege A, Mrowka R, Brown R, Spielmann N, Persson PB, Fredholm BB, Persson AE. Contribution of adenosine receptors in the control of arteriolar tone and adenosine-angiotensin II interaction. Kidney Int 70: 690–698, 2006
20. Lee HT, Emala CW. Characterization of adenosine receptors in human kidney proximal tubule (HK-2) cells. Exp Nephrol 10: 383–392, 2002
21. 3 receptors. Am J Physiol Renal Physiol 278: F380–F387, 2000
22. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 15: 298–306, 1994
23. 3 adenosine receptor with widespread tissue distribution. Mol Pharmacol 44: 524–532, 1993
24. Lu Y, Fu Y, Ge Y, Juncos LA, Reckelhoff JF, Liu R. The vasodilatory effect of testosterone on renal afferent arterioles. Gend Med 9: 103–111, 2012
25. 1 receptor antagonists and the kidney. Curr Opin Nephrol Hypertens 12: 497–502, 2003
26. Morton MJ, Sivaprasadarao A, Bowmer CJ, Yates MS. Adenosine receptor mRNA levels during postnatal renal maturation in the rat. J Pharm Pharmacol 50: 649–654, 1998
27. 2A receptors on renal microvascular reactivity. Am J Physiol Renal Physiol 280: F406–F414, 2001
28. Nishiyama A, Navar LG. ATP mediates tubuloglomerular feedback. Am J Physiol Regul Integr Comp Physiol 283: R273–R279, 2002
29. Osswald H, Hermes HH, Nabakowski G. Role of adenosine in signal transmission of tubuloglomerular feedback. Kidney Int Suppl 12: S136–S142, 1982
30. 3 adenosine receptor. Biochim Biophys Acta 1179: 105–107, 1993
31. 3 adenosine receptor. Proc Natl Acad Sci USA 90: 10365–10369, 1993
32. Schnermann J, Levine DZ. Paracrine factors in tubuloglomerular feedback: adenosine, ATP, and nitric oxide. Annu Rev Physiol 65: 501–529, 2003
33. Spielman WS, Thompson CI. A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am J Physiol Renal Fluid Electrolyte Physiol 242: F423–F435, 1982
34. Sun D, Samuelson LC, Yang T, Huang Y, Paliege A, Saunders T, Briggs J, Schnermann J. Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci USA 98: 9983–9988, 2001
35. Tilley SL, Wagoner VA, Salvatore CA, Jacobson MA, Koller BH. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest 105: 361–367, 2000
36. Vallon V, Muhlbauer B, Osswald H. Adenosine and kidney function. Physiol Rev 86: 901–940, 2006
37. Vitzthum H, Weiss B, Bachleitner W, Kramer BK, Kurtz A. Gene expression of adenosine receptors along the nephron. Kidney Int 65: 1180–1190, 2004
38. Weaver DR, Reppert SM. Adenosine receptor gene expression in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 263: F991–F995, 1992
39. 1 receptor mRNA in microdissected rat nephron segments. Hypertension 26: 1181–1185, 1995
40. 3 adenosine receptor. Proc Natl Acad Sci USA 89: 7432–7436, 1992
41. Zou AP, Wu F, Li PL, Cowley AW Jr. Effect of chronic salt loading on adenosine metabolism and receptor expression in renal cortex and medulla in rats. Hypertension 33: 511–516, 1999.